# Editorial: Emerging trends in real-world pharmacoepidemiology: 2023

**Authors:** Mohammed S. Salahudeen, Tatiane Da Silva Dal Pizzol, Li-Ting Kao, Gregory M. Peterson

PMC · DOI: 10.3389/fphar.2025.1601477 · Frontiers in Pharmacology · 2025-04-15

## Full-text entities

- **Diseases:** critically ill (MESH:D016638), PV (MESH:D011087), liver injury (MESH:D017093), pulmonary haemorrhage (MESH:D006474), TD (MESH:D004409), tumor lysis syndrome (MESH:D015275), melanoma (MESH:D008545)
- **Chemicals:** L (MESH:D007930), CDK4/6 (-), cenobamate (MESH:C000654784), dexmedetomidine (MESH:D020927), binimetinib (MESH:C581313), vancomycin (MESH:D014640), enoxaparin (MESH:D017984), encorafenib (MESH:C000601108), bevacizumab (MESH:D000068258)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12037602/full.md

## References

9 references — full list in the complete paper: https://tomesphere.com/paper/PMC12037602/full.md

---
Source: https://tomesphere.com/paper/PMC12037602